COVID-19 Impact on Launch Performance

Home / Intelligence / Webinars / COVID-19 Impact on Launch Performance

How has COVID-19 impacted launch performance and timing?

Pharmaceutical leaders are facing some of the toughest challenges of their careers when it comes to launching in the midst of COVID-19. With so much at stake and so much uncertainty, companies are looking for fact-based insights to power their decision-making.

Trinity has done an in-depth evaluation of the impact of COVID-19 on launch performance and timing. We have compared forecasted/expected revenue to actual revenue for products that launched within six months of COVID-19. We have also explored products that received approval during COVID-19 but have had to delay launch.

Join us to hear the findings and get answers that will help you predict the impact on your product launches.

Key Topics

  • Case studies of recently launched products that experienced significant challenges and successes through COVID-19
  • Insights into the types of product and market factors that contributed to these successes and challenges
  • A review of companies that delayed product launches and the impact of COVID-19 on expected FDA approval dates

Fill out the fields below to view “Webinar: COVID-19 Impact on Launch Performance.”

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.